Searched for
PHARMACEUTICAL APPROVAL IN CHINA
India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- 12 years of PM Modi: Bold reforms, decisive decisions and political turning pointsAfter 12 years at the helm, Prime Minister Narendra Modi reflects on a transformative journey filled with key reforms that have altered Ind...
- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
- India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
- India’s rising export champion faces a critical credibility testIndia's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and ...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- India eyes Myanmar rare earths as President Min Aung Hlaing visitsMyanmar President Min Aung Hlaing's visit to India presents a significant opportunity for New Delhi. India aims to secure rare earth minera...
- Want to jump into the 'China is back' rally? Tread carefullyInvestors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...
- India’s 'China-plus-one' push needs tax ease and fast-track FTAs with developed nations: Arvind VirmaniIndia must reform its tax system and streamline clearances to attract global investments moving away from China. Economist Arvind Virmani e...
- From axles to rare earth: India draws up list of 100 products it still can't make enough ofIndia is set to boost its manufacturing sector by identifying around 100 products for domestic production. This initiative aims to reduce r...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Govt has eased FDI norms for foreign cos having small Chinese/Hong Kong stake: An explainerIndia has eased Foreign Direct Investment rules for companies with up to ten percent Chinese or Hong Kong shareholding. These firms can now...
- Prototype Fast Breeder Reactor reaches criticality, boosts India’s nuclear programme: Dr SC ChetalA key figure in India’s fast breeder nuclear programme has highlighted the significance of the Prototype Fast Breeder Reactor (PFBR) achiev...
- FDI easing for foreign cos with up to 10 pc Chinese stake to be notified soon under FEMAIndia is on the verge of a significant policy alteration, planning to loosen foreign investment regulations for firms that include Chinese ...
- India’s trade map enters a world that’s threatened by missiles & bombsIndia's ambitious trade deals are now facing their crucial test. Agreements signed with countries like the UK and Oman are in transition. W...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Glenmark’s nasal spray Ryaltris gets China’s NMPA nod for allergic rhinitis; to be commercialised by Grand PharmaRyaltris is a fixed-dose combination of olopatadine, an antihistamine and mometasone furoate, a corticosteroid to treat the symptoms of all...
- China's plans to import Indian drugs fail to enthuse Indian pharmaceutical firmsOn May 4, China said it had removed import duties on as many as 28 medicines, but the need for lengthy trials and approvals has dampened en...
- China luring Indian pharma scientists with 3 times higher pay to boost formulations segmentThe poaching from across the border could threaten the Indian drug makers and further heat up competition between the two Asian economies.
Load More
